Terms: = Ovarian cancer AND HOXA9, HOX1, 3205, ENSG00000078399, HOX1G, P31269 AND Clinical Outcome
1 results:
1. Circulating hoxa9-methylated tumour DNA: A novel biomarker of response to poly (ADP-ribose) polymerase inhibition in BRCA-mutated epithelial ovarian cancer.
Rusan M; Andersen RF; Jakobsen A; Steffensen KD
Eur J Cancer; 2020 Jan; 125():121-129. PubMed ID: 31865042
[TBL] [Abstract] [Full Text] [Related]